Skip to main navigation Skip to search Skip to main content

Prospective, Multicenter Study Of The Mtor Inhibitor Everolimus (RAD001) As Primary Therapy In Waldenstrom’s Macroglobulinemia

  • Steven Peter Treon
  • , Christina K Tripsas
  • , Kirsten Meid
  • , Christopher Patterson
  • , Leonard T Heffner
  • , Herbert Eradat
  • , Stephanie A. Gregory
  • , Sheeba K. Thomas
  • , Ranjana H. Advani
  • , Rachid Baz
  • , Ashraf Z. Badros
  • , Jeffrey Matous
  • , Timothy J. Murphy
  • , Irene M. Ghobrial
  • Harvard University
  • Emory University
  • University of California, Los Angeles
  • Rush University Medical Center
  • University of Texas MD Anderson Cancer Center
  • Stanford University
  • Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA,
  • University of Maryland, Baltimore
  • Colorado Blood Cancer Institute, Denver, CO, USA,
  • University of Colorado Colorado Springs

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalBlood
Volume122
Issue number21
DOIs
StatePublished - Nov 18 2011
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Gastroenterology
  • Internal Medicine

Cite this